UPC APP 33456/2025

—·EP2726883: A CELL MEDIATED IMMUNE RESPONSE ASSAY WITH ENHANCED SENSITIVITY

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Sonstige prozessuale
Parteien: Kläger
QIAGEN Sciences, LLC
Vertreter: Clemens Plassmann (Hogan Lovells International LLP); Markus Kuczera (Hogan Lovells International LLP); Chia C. Chuong (Hogan Lovells International LLP)
Beklagte
bioMérieux SA
bioMérieux Deutschland GmbH
Vertreter: Oliver Jan Jüngst (Bird & Bird LLP); Annika L. Lückemann (Bird & Bird LLP)
Division: Dusseldorf LD
Richter: Jule Schumacher · Judge-rapporteur
Technology: Measurement & Testing
Sprache: —
Erste Entscheidung: 23. Juli 2025

Entscheidungen

2025-07-23
Generic application
The Düsseldorf Local Division issued a procedural order extending a time period under Rule 9.3 RoP in an infringement action. The order relates to the protection of confidential information contained in the defendants' statement of defence and supporting exhibits regarding peptides used by the defendants and related analyses.
Rechtsfragen:Extension of time period under Rule 9.3 RoPProtection of confidential information under Rule 262A RoP

Dokumente